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PHARMACY
Patient Information Brochure
Medication errors are important cause of 
healthcare associated patient harm. Errors 
can occur at the stage of prescribing, 
transcribing, dispensing and administration. 
Studies estimated that about 38% medication 
errors occur at the time of administration 
and lack of patient’s knowledge about drugs 
is a major contributing cause. In order to 
provide better understanding of medication 
use, a group of pharmacists deliberated 
on the subject and prepared easy-to-
comprehend patient medication Information 
brochures 
of selected 
critical medications. These  seven 
brochures are single page handout both 
in English and Urdu translation designed 
in order to enhance the awareness among 
the patients who are using these critical 
medications for chronic illnesses. 
With the intent to reduce patient harm by 
making our patients more educated, this will 
build better relationship with the patients 
along with increase satisfaction level.
“Beers Criteria”– Medication Safety in 
Elderly Patients
Contributed by: Zulfiqar Khalil (Intern Pharmacist)
Geriatrics is a special population of patients with increased risk of 
adverse effects and medication errors. In 1991, Dr. Mark Beers and 
colleagues published criteria developed by consensus and literature review 
identifying inappropriate medication use among institutionalized elderly 
patients. Since 1991, these criteria have been updated and presently, the 
Beers criteria (Beers List) is one of the most widely cited criteria for 
inappropriate medication use in older adults aged 65 years or greater.
The Beers criteria cover 3 categories of inappropriate medication use:
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RecommendationRationale
Anticholinergics (excludes 
TCAs) - First-generation 
antihistamines
(as single agent or as part of
combination products)
Chlorpheniramine
Clemastine, Cyproheptadine
Diphenhydramine (oral)
Doxylamine, Hydroxyzine
Promethazine, Triprolidine
Antispasmodics - Belladonna 
alkaloids
Clidinium-chlordiazepoxide
Dicyclomine
Hyoscyamine
Anti-infective 
Nitrofurantoin 
Cardiovascular - Alpha1 
blockers
Doxazosin
Prazosin
Terazosin
Antiarrhythmic drugs (Class Ia, 
Ic, III)
Amiodarone
Flecainide
Procainamide
Quinidine
Digoxin > 0.125 mg/d
Highly anticholinergic; clearance reduced with 
advanced age, and tolerance develops when used 
as hypnotic; greater risk of confusion, dry mouth, 
constipation, and other anticholinergic effects and 
toxicity.
Use of diphenhydramine in special situations
such as acute treatment of severe allergic reaction 
may be appropriate
Highly anticholinergic, uncertain effectiveness
Potential for pulmonary toxicity; safer 
alternatives available; lack of efficacy in patients 
with CrCl < 60 mL/min due to inadequate drug 
concentration in the urine 
High risk of orthostatic
hypotension; not recommended as routine 
treatment for hypertension;
alternative agents have superior risk/benefit 
profile
Amiodarone is associated with multiple 
toxicities, including thyroid disease, 
pulmonary disorders, and QT- interval 
prolongation
In heart failure, higher dosages associated with 
no additional benefit and may increase risk of 
toxicity; slow renal clearance may lead to risk of 
toxic effects
Avoid
Avoid except in
short-term 
palliative care to 
decrease oral 
secretions
Avoid for long-
term suppression; 
avoid in patients with 
 CrCl <60mL/min
Avoid use as an
antihypertensive
Avoid 
antiarrhythmic
drugs as first-line
treatment of atrial
fibrillation
Avoid
Hydroxyzine 
and 
promethazine: 
high;
All others: 
moderate
Moderate
Moderate
Moderate
High
Moderate
Strong
Strong
Strong
Strong
Strong
Strong
Note: Only selected medications are depicted in this table, for details please refer to full text in J Am Geriatr Soc 2012 (American Geriatrics 
Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults)
(1)  Medications/ classes of medications that  
 should generally be avoided in patients 65  
 years or older because are either ineffective, 
 or pose an unnecessary risk for older patients 
 and a safer   
 alternative is   
 available.
(2)  Medications that  
 should be avoided  
 in older persons
 known to have 
 specific medical  
 conditions; and/or
(3)  Medications to be used with caution. With 
 each recommendation, the quality of 
 supporting evidence is ranked as low, 
 moderate, or high, and the strength of each 
 recommendation is rated as strong, weak, or 
 insufficient.
The following table represents the Beers 
Criteria listing the categories of inappropriate 
medication use by drug along with the strength of 
recommendation rating, and quality of supporting 
evidence.
Central nervous system 
Tertiary TCAs
Amitriptyline, Clomipramine
Imipramine
Benzodiazepines 
Short and intermediate acting:
Alprazolam
Lorazepam
Temazepam
Long acting:
Chlordiazepoxide
Clidinium-chlordiazepoxide
Clonazepam
Diazepam
Nonbenzodiazepine hypnotics 
Zolpidem
Sulfonylureas 
Glibenclamide
NSAIDs:
Aspirin > 325 mg/d
Diclofenac
Ibuprofen
Ketoprofen
Mefenamic acid
Meloxicam
Naproxen
Piroxicam
Indomethacin
Ketorolac
Muscle Relaxants
Orphenadrine
Highly anticholinergic, sedating,
and cause orthostatic hypotension
Older adults have increased
sensitivity to benzodiazepines and slower 
metabolism of long-acting agents. In general, 
all benzodiazepines increase risk of cognitive 
impairment, delirium, falls, fractures, and motor 
vehicle accidents in older adults.
May be appropriate for seizure, REM sleep 
disorders, benzodiazepine or ethanol withdrawal, 
severe generalized anxiety disorder, periproce-
dural anesthesia, end-of-life care
Same as above
Greater risk of severe
prolonged hypoglycemia in older adults 
Increases risk of GI bleeding and peptic ulcer 
disease in high-risk groups, including those aged 
> 75 or taking oral or parenteral corticosteroids, 
anticoagulants, or antiplatelet agents. Use of 
proton pump inhibitor or misoprostol reduces but 
does not eliminate risk. Upper GI ulcers, gross 
bleeding, or perforation caused by NSAIDs occur 
in approximately 1% of patients treated for 3–6 
months and in approximately 2–4% of patients 
treated for 1 year. These trends continue with 
longer duration of use
Most muscle relaxants are poorly tolerated 
because of anticholinergic adverse effects, 
sedation, risk of fracture
Avoid
Avoid 
benzodiazepines
(any type) for 
treatment of 
insomnia, agitation, 
or delirium
Avoid chronic use
(> 90 days)
Avoid
Avoid chronic use
unless other 
alternatives are 
not effective and 
patient can take 
gastroprotective 
agent (proton pump 
inhibitor
or misoprostol)
Avoid
High
High
Moderate
High
Moderate 
Ketorolac: 
high
Moderate
Strong
Strong
Strong
Strong
Strong
Strong
Organ System or 
Therapeutic Category
Quality of
Evidence
Strength of
Recommendation
Adverse Drug 
Reactions – Summary 2012
Adverse drug reaction are any response to 
a drug that is noxious, unintended and that 
occurs at doses normally used for prophylaxis, 
diagnosis or therapy. The main purpose 
of ADR reporting and monitoring is to 
provide an indirect measure of the quality of 
pharmaceutical care through identification of 
preventable ADRs and anticipatory surveillance 
for high-risk drugs or patients. The data will 
help to monitor trends and significant isolated 
ADRs, create a feedback loop to practitioners, 
promote educational endeavors to prevent 
ADRs, and improve patient outcomes. 
In the year 2012, a total number of 135 
ADRs were reported (with exception of many 
unreported too). Following are the details of 
reported ADRs:
Antibiotics:
In the year 2012, majority of ADRs were reported 
from antibiotic class of drugs. These mainly were 
rashes and hypersensitivity reactions.
Learning outcomes:
l All antibiotics must be infused slowly over a  
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 period time recommended by the drug 
 information resources (mention on the patient 
 labels).
l Avoid administration of antibiotics in high 
 concentrations where possible, decrease rate 
 of infusion if using maximum 
 concentration of dilution.
l If patient develops allergy or hypersensitivity 
 to any antibiotic it must be documented in 
 patient record and updated in the Pharmacy 
 system to avoid any further administration.
Reported ADRs 2012
Antipsychotics:
The second most frequently reported ADRs were 
from Neuroleptics class of drugs. Extra Pyramidal 
Symptoms (EPS), tremor and dystonia were highest 
in this class. Neuroleptics induced movement 
disorders are caused by medications that block the 
action of dopamine. 
Learning Outcomes:
l Antipsychotic induced EPS and movement  
 disorders are well documented in the literature;  
 clinicians should anticipate these reactions.
l Elderly patients are usually at high risk. Start  
 the therapy of antipsychotic medications with  
 low doses and gradually increase the dose.
l In order to avoid drug induced postural tremor  
 and daytime tremor elderly patients should take  
 the antipsychotics at bedtime.
l To prevent acute dystonia, a preventative  
 medication along with the antipsychotic such as  
 procyclidine, trihexyphenidyl, diphenhydramine  
 etc. can also be prescribed. 
 ADR Reporting:
 Adverse drug Reactions are reported in AKUH  
 through;
	 l Yellow Cards
	 l http://intranet/pharmacy/adrrf.htm
 Vote of thanks to all the Physicians, 
Nurses and Pharmacists who spared some 
time for patient safety and reported 
ADRs last Year. 
